Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it\'s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Artificial Blood Vessel is a substitute of vascular. It was developed successfully and begins clinical application in the 1950s. Artificial blood vessel requirements include stable physical and chemical properties; mesh suitable degree; have a certain strength and flexibility; easy to sew bypass surgery when making good; no bleeding or oozing blood when small blood vessels and can be turned on instantly stop; after Implantation of human tissue reactions were mild; human tissue can rapidly form the inner and outer membrane newborn; difficult thrombosis; and satisfactory long-term patency. Currently EPTFE, Polyethylene Terephthalate and Polyurethane are used in the manufacture of an artificial blood vessel which is widely used in aortic disease, peripheral vascular disease and hemodialysis.
Consider the global manufacture of Artificial Blood Vessel, Europe and the United States is the major producing regions, the main production companies are concentrated in this area, such as Maquet, Terumo, Gore, B. Braun, Bard, Jotec GmbH, LeMaitre Vascular, Perouse Medical and Nicast. The total production of artificial blood vessel 168450 units in US, whose occupies above 55.69% of total production in 2015. 117300 units were produced in Europe, accounting for more than 38.78% in 2015. 1730 units were produced by Chinese native manufacture in 2015.
The main production areas and consumption areas are concentrated in the United States and European. US and Europe consumption is about 37.50% and 33.26%. The market is mature and stable. China's consumer market share continues to expand. The United States is the world's largest export country, China is still depends on import.
The report offers detailed coverage of Artificial Blood Vessel industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Artificial Blood Vessel by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Artificial Blood Vessel market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Artificial Blood Vessel market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Maquet Cardiovascular
Terumo Group
Gore
B. Braun
Bard
Jotec GmbH
LeMaitre Vascular
Perouse Medical
Nicast
ShangHai CHEST
SuoKang
At the same time, we classify Artificial Blood Vessel according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
EPTFE
Polyethylene Terephthalate
Polyurethane
Others
Market by Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Artificial Blood Vessel market for the forecast period 2021 - 2025?
• What are the driving forces in the Artificial Blood Vessel market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Artificial Blood Vessel industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?